Investor Relations

SI-BONE is a global leader in technology for surgical treatment of sacropelvic disorders. In 2009, SI-BONE pioneered a proprietary minimally invasive surgical system, the iFuse Implant System^®, to fuse the SI joint and treat SI joint dysfunction. Tens of thousands of patients have subsequently been treated with iFuse by thousands of trained physicians around the world. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 135 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma. The expanded iFuse Technology^® platform now includes iFuse 3D™, iFuse TORQ^®, iFuse TORQ TNT™,  and iFuse Bedrock Granite^®.